New research indicates that weight loss medications like GLP-1s may cause cancer scans to appear abnormal, potentially leading to unnecessary follow-up tests, and could also diminish the effectiveness of breast cancer chemotherapy. Experts recommend thorough patient history reviews prior to treatment, highlighting the need for further studies on these drugs’ impacts.
Want More Context? 🔎
Loading PerspectiveSplit analysis...
